Fix the following errors:
Launch Excellence
Download White Paper
To download our latest white paper on Specialty Brands, please complete the form below.
Specialty products came onto the scene in dramatic fashion in 2010 and they have delivered strong growth in the years since. Yet, their success has had some unintended consequences for the economics of our health system. This trend is forcing payers to aggressively manage their budgets in ways that are unfortunately dampening revenues for specialty brand manufactures.
Implications of a Dynamic Launch Environment
QuintilesIMS conducted an analysis to quantify the full impact of launches pre- and post-hepatitis C era. Findings included that the differential between innovative brands and non-innovative brands is diminishing at an alarming rate. In fact, the fill rates for highly innovative brands are down more than 50% in the last 2 years. The author of this white paper, William McClellan, Center of Excellence
Leader, Launch Excellence will explore the analysis and help you better understand how payer reaction to high-cost launches has been to restrict patient access to new therapies, particularly for innovative treatments.
Download the white paper to learn about the implications on launch brands including:
- What demonstrated best practices manufacturers must modify to account for these market forces
- How to avoid paying double for access
- Whether innovation is still rewarded